THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 38 filers reported holding THERAPEUTICSMD INC in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $402,095 | -27.0% | 133,144 | -0.4% | 0.00% | – |
Q2 2023 | $550,960 | +9.9% | 133,728 | 0.0% | 0.00% | – |
Q1 2023 | $501,480 | -32.8% | 133,728 | +0.2% | 0.00% | – |
Q4 2022 | $746,159 | -17.7% | 133,481 | -2.3% | 0.00% | – |
Q3 2022 | $907,000 | -35.4% | 136,588 | -3.1% | 0.00% | – |
Q2 2022 | $1,403,000 | – | 140,947 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 317,313 | $1,773,780 | 1.02% |
Rubric Capital Management LP | 1,757,191 | $9,822,698 | 0.43% |
Clearline Capital LP | 234,040 | $1,308,283 | 0.23% |
SANDERS MORRIS HARRIS LLC | 40,393 | $225,797 | 0.08% |
XR Securities LLC | 41,200 | $230,308 | 0.02% |
EQUITEC PROPRIETARY MARKETS, LLC | 9,500 | $53,105 | 0.02% |
EQUITEC PROPRIETARY MARKETS, LLC | 9,500 | $53,105 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 42,000 | $234,780 | 0.01% |
J. Goldman & Co LP | 13,562 | $75,812 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 38,042 | $212,655 | 0.00% |